Latest News
Chance Pharma reports NMPA acceptance of NDA for investigational respiratory drug CXG87
8 May 2026 - Chance Pharmaceuticals, a clinical-stage biotech company focused on the research and development of innovative dry powder inhalation (DPI) therapies, announced on Thursday that the Center for Drug Evaluation of China's National Medi...
Halozyme and GSK sign global drug‑delivery collaboration
...
Altasciences and Certara form strategic partnership to accelerate early drug development
7 May 2026 - Drug development solution company Altasciences announced on Thursday that it has entered into a strategic partnership with biosimulation software specialist Certara Inc (NASDAQ:CERT) to accelerate early-phase development programs.This co...
Kaiser Permanente reports study findings showing significant cost savings
7 May 2026 - Health care provider Kaiser Permanente said on Wednesday that it has commissioned Milliman, a global actuarial and professional services consulting firm, to conduct a study comparing Kaiser Permanente's 2023 prescription drug costs ...
Partner Therapeutics' BIZENGRI receives FDA Commissioner's National Priority Voucher for NRG1 fusion-positive cholangiocarcinoma
7 May 2026 - Biotechnology company Partner Therapeutics Inc (PTx) announced on Wednesday that the US Food and Drug Administration (FDA) has awarded a Commissioner's National Priority Voucher (CNPV) pilot program voucher for BIZENGRI (zenocutuzum...